February 18, 2025

Biodistribution Assessment of Lipid Nanoparticle-Mediated mRNA Delivery Using In Vivo Imaging

Cayman Chemical’s LNP development services in partnership with Labcorp utilizes in vivo imaging technology to create a comprehensive LNP screening platform. With this approach, three LNP formulations were assessed in vitro and in vivo for potency of reporter gene expression and differential organ delivery. This comprehensive LNP formulation, characterization, and analysis service can be used to identify candidate LNP formulations with tissue-tropic distribution.
<span>Seven tips to reduce heart disease risk</span>
February 10, 2025

Seven tips to reduce heart disease risk

Our hearts are the engines that power our lives, so taking care of them should be a top priority. Unfortunately, heart disease is still the leading cause of mortality in the United States. But the good news is it’s also largely preventable through simple lifestyle changes. February is American Heart Month and a great time to look at the modifiable risk factors for developing this disease. After all, the key to a healthier heart is largely in your hands.
<span>Labcorp Announces 2024 Fourth Quarter and Full Year Results</span>
February 6, 2025

Labcorp Announces 2024 Fourth Quarter and Full Year Results

Company Provides 2025 Guidance Results from Continuing Operations versus last year: Revenue: Q4 of $3.33 billion vs $3.03 billion ; Full year of $13.01 billion vs $12.16 billion Diluted EPS: Q4 of $1.70 vs $(1.95) ; Full year of $8.84 vs $4.33 Adjusted EPS: Q4 of $3.45 vs $3.30 ; Full year of
<span>How lab data enables more accurate patient coding for value-based care success</span>
February 7, 2025

How lab data enables more accurate patient coding for value-based care success

As the healthcare landscape continues to evolve, value-based care is playing a pivotal role in enhancing patient outcomes while effectively managing costs. For providers engaged in value-based care programs, accurate patient coding isn’t just important—it's essential for achieving success. Unfortunately, many ACOs and Medicare Advantage networks face significant challenges due to coding inaccuracies, which can hinder their progress toward performance goals and cost savings. Fortunately, leveraging national laboratory data offers a promising solution. In this article, Labcorp's Brian Buesing, Vice President of commercial efforts for large physician organizations and value-based care networks, shares his insights.